Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12208 | 30561273 | Radiology | Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study. | 2018 | Details |
| A12209 | 30561132 | Basic Clin Pharmacol Toxicol | A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease. | 2019 | Details |
| A12210 | 30561027 | Aliment Pharmacol Ther | Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease. | 2018 | Details |
| A12211 | 30560362 | Eur Radiol | Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model. | 2018 | Details |
| A12213 | 30560336 | Dig Dis Sci | Incidence of Recurrent NASH-Related Allograft Cirrhosis. | 2018 | Details |
| A12214 | 30559861 | Open Access Maced J Med Sci | The Comparison of Simple Anthropometric and Biochemical Parameters for Predicting Liver Steatosis in Obese Balinese Young Women. | 2018 | Details |
| A12216 | 30559308 | Mol Cell Biol | Rapid Recapitulation of Nonalcoholic Steatohepatitis upon Loss of Host Cell Factor 1 Function in Mouse Hepatocytes | 2019 | Details |
| A12217 | 30559024 | J Pediatr | Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. | 2018 | Details |
| A12218 | 30558790 | Biochem Biophys Res Commun | Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease. | 2018 | Details |
| A12219 | 30558054 | Medicine (Baltimore) | Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting. | 2018 | Details |
| A12220 | 30557902 | Diabetes Metab Res Rev | Apolipoprotein CIII and diabetes. Is there a link? | 2019 | Details |
| A12221 | 30557833 | Biomed Pharmacother | Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol. | 2018 | Details |
| A12222 | 30557738 | Clin Gastroenterol Hepatol | Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis. | 2018 | Details |
| A12223 | 30556145 | Hepatology | Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12224 | 30556038 | Hepatol Commun | Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12225 | 30556037 | Hepatol Commun | Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice. | 2018 | Details |
| A12226 | 30556036 | Hepatol Commun | A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12227 | 30556032 | Hepatol Commun | Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease. | 2018 | Details |
| A12228 | 30555521 | Nutr Metab (Lond) | Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice. | 2018 | Details |
| A12229 | 30555477 | Front Immunol | Macrophages in the Aging Liver and Age-Related Liver Disease. | 2018 | Details |
| A12231 | 30554783 | Lancet | Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial. | 2018 | Details |
| A12232 | 30554468 | Liver Int | Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals. | 2018 | Details |
| A12233 | 30553982 | J Pharm Biomed Anal | Lipidomic analysis reveals the efficiency of Eclipta prostrata on diet-induced nonalcoholic fatty liver disease in rats. | 2018 | Details |
| A12234 | 30553186 | Micron | Primary cultured neuronal networks and type 2 diabetes model mouse fatty liver tissues in aqueous liquid observed by atmospheric SEM (ASEM): Staining preferences of metal solutions. | 2018 | Details |
| A12235 | 30553055 | Biochim Biophys Acta Mol Cell Biol Lipids | Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease. | 2018 | Details |
| A12237 | 30551665 | Children (Basel) | Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12238 | 30551613 | Nutrients | Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome. | 2018 | Details |
| A12239 | 30551393 | Biomed Pharmacother | Enhanced hepatic glycogen synthesis and suppressed adenosine deaminase activity by lithium attenuates hepatic triglyceride accumulation in nicotine-exposed rats. | 2018 | Details |
| A12240 | 30551380 | Biomed Pharmacother | Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism. | 2018 | Details |
| A12241 | 30551370 | Biomed Pharmacother | Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes. | 2018 | Details |
| A12242 | 30551263 | J Gastroenterol Hepatol | Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. | 2019 | Details |
| A12243 | 30550414 | Curr Opin Lipidol | Lipoprotein metabolism in liver diseases. | 2019 | Details |
| A12244 | 30549292 | Hepatology | Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials. | 2019 | Details |
| A12245 | 30548700 | Echocardiography | Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation. | 2018 | Details |
| A12247 | 30548128 | Liver Transpl | Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation. | 2019 | Details |
| A12248 | 30547890 | Eur Cytokine Netw | Obesity and inflammation. | 2018 | Details |
| A12249 | 30547786 | BMC Med Genomics | Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. | 2018 | Details |
| A12250 | 30547371 | Adv Ther | Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study. | 2018 | Details |
| A12251 | 30547370 | Pharmacoeconomics | Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand. | 2019 | Details |
| A12253 | 30545408 | J Med Case Rep | Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports. | 2018 | Details |
| A12254 | 30545385 | Lipids Health Dis | Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study. | 2018 | Details |
| A12255 | 30544824 | Int J Mol Sci | Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender. | 2018 | Details |
| A12256 | 30544653 | Int J Mol Sci | miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. | 2018 | Details |
| A12257 | 30544632 | J Clin Med | Liver Fat Content and Body Fat Distribution in Youths with Excess Adiposity. | 2018 | Details |
| A12258 | 30543782 | Chem Biol Interact | Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states. | 2018 | Details |
| A12259 | 30543441 | Mol Pharm | Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice. | 2018 | Details |
| A12260 | 30542827 | Obes Surg | Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients. | 2019 | Details |
| A12261 | 30541716 | Turk J Gastroenterol | Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease. | 2019 | Details |
| A12262 | 30525304 | Mol Nutr Food Res | SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. | 2018 | Details |
| A12263 | 30523118 | Proc Natl Acad Sci U S A | Modulation of HIF-2α PAS-B domain contributes to physiological responses. | 2018 | Details |
| A12264 | 30522586 | J Pharm Pharm Sci | Resveratrol Limits Lipogenesis and Enhance Mitochondrial Activity in HepG2 Cells. | 2018 | Details |
| A12265 | 30522446 | BMC Infect Dis | Is Toxoplasma gondii infection correlated with nonalcoholic fatty liver disease?- a population-based study. | 2018 | Details |
| A12266 | 30541128 | J Clin Endocrinol Metab | The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet. | 2019 | Details |
| A12267 | 30541001 | Ann Nutr Metab | Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study. | 2018 | Details |
| A12268 | 30540727 | Rev Gastroenterol Peru | [Hepatopulmonar syndrome and liver transplantation: experience in the transplantation department of the Guillermo Almenara Irigoyen National Hospital - EsSalud]. | 2019 | Details |
| A12269 | 30540726 | Rev Gastroenterol Peru | [Liver transplant and hepatocellular carcinoma in Peru: outcome after 15 years in the transplant department of the Guillermo Almenara Hospital - EsSalud]. | 2019 | Details |
| A12270 | 30540086 | Arq Gastroenterol | CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. | 2019 | Details |
| A12271 | 30539788 | Cell Mol Gastroenterol Hepatol | Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12272 | 30539516 | Hepatol Int | Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka. | 2018 | Details |
| A12273 | 30538805 | Oxid Med Cell Longev | c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types. | 2018 | Details |
| A12274 | 30538803 | Oxid Med Cell Longev | Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE-/- Mice. | 2018 | Details |
| A12275 | 30537758 | Digestion | Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research. | 2018 | Details |
| A12276 | 30537742 | Cell Physiol Biochem | Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism. | 2018 | Details |
| A12277 | 30537674 | Biomed Pharmacother | Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway. | 2018 | Details |
| A12278 | 30537110 | Mol Nutr Food Res | Combination of Whole Grapeseed Flour and Newly Isolated Kefir Lactic Acid Bacteria Reduces High-Fat-Induced Hepatic Steatosis. | 2018 | Details |
| A12279 | 30536914 | J Physiol | Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. | 2019 | Details |
| A12280 | 30536602 | Liver Int | Atrial fibrillation is highly prevalent yet undertreated in patients with biopsy-proven nonalcoholic steatohepatitis. | 2018 | Details |
| A12281 | 30536539 | J Cell Mol Med | The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. | 2018 | Details |
| A12282 | 30534868 | Rev Med Chil | [Management of non-alcoholic fatty liver disease]. | 2018 | Details |
| A12283 | 30534793 | Food Funct | Dietary methionine restriction reduces hepatic steatosis and oxidative stress in high-fat-fed mice by promoting H2S production. | 2019 | Details |
| A12284 | 30533221 | J Obes | Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression. | 2018 | Details |
| A12285 | 30533179 | World J Hepatol | Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? | 2018 | Details |
| A12286 | 30529590 | J Hepatol | Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis. | 2018 | Details |
| A12287 | 30529260 | Food Chem Toxicol | Mechanistic insights of hepatoprotective effects of curcumin: Therapeutic updates and future prospects. | 2018 | Details |
| A12288 | 30528844 | Clin Gastroenterol Hepatol | FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage. | 2018 | Details |
| A12289 | 30528710 | Dig Liver Dis | Salivary markers of hepato-metabolic comorbidities in pediatric obesity. | 2018 | Details |
| A12290 | 30528647 | Biochim Biophys Acta Rev Cancer | Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans. | 2018 | Details |
| A12291 | 30527903 | Hepatobiliary Pancreat Dis Int | Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. | 2018 | Details |
| A12292 | 30527843 | Ultrasound Med Biol | Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse Models. | 2018 | Details |
| A12293 | 30526624 | J Transl Med | L-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice. | 2018 | Details |
| A12294 | 30522122 | Cell Physiol Biochem | Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression. | 2018 | Details |
| A12295 | 30522014 | Biomed Pharmacother | Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. | 2018 | Details |
| A12296 | 30521580 | PLoS One | E4orf1: A protein for enhancing glucose uptake despite impaired proximal insulin signaling. | 2018 | Details |
| A12297 | 30520566 | Obesity (Silver Spring) | Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study. | 2018 | Details |
| A12298 | 30520543 | Cancer Sci | Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet. | 2019 | Details |
| A12300 | 30519965 | Acta Diabetol | A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? | 2018 | Details |
| A12301 | 30519850 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature. | 2018 | Details |
| A12302 | 30518830 | Nat Rev Gastroenterol Hepatol | Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. | 2019 | Details |
| A12303 | 30508576 | Free Radic Biol Med | Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects. | 2018 | Details |
| A12304 | 30508523 | Biochem Pharmacol | Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. | 2018 | Details |
| A12305 | 30507741 | Transplantation | Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. | 2019 | Details |
| A12306 | 30506860 | J Gastroenterol Hepatol | Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index. | 2019 | Details |
| A12307 | 30506692 | Aliment Pharmacol Ther | Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD. | 2018 | Details |
| A12308 | 30506586 | Hepatology | Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. | 2019 | Details |
| A12309 | 30505829 | Front Pediatr | Is There an Association of Vascular Disease and Atherosclerosis in Children and Adolescents With Obesity and Non-alcoholic Fatty Liver Disease? | 2018 | Details |
| A12310 | 30504232 | J Lipid Res | Hepatic transcriptome analysis from HFD-fed mice defines a long noncoding RNA regulating cellular cholesterol levels. | 2018 | Details |
| A12312 | 30503530 | Clin Biochem | A simpler diagnostic formula for screening nonalcoholic fatty liver disease. | 2018 | Details |
| A12313 | 30502373 | Metabolism | Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. | 2018 | Details |
| A12314 | 30502056 | EBioMedicine | Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study. | 2018 | Details |
| A12315 | 30502049 | Am J Cardiol | Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance. | 2018 | Details |